EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter international randomized study of oxaliplatin/5FU/LV in stage II and III colon cancer Final results



Multicenter international randomized study of oxaliplatin/5FU/LV in stage II and III colon cancer Final results



EJC Supplements 1(5): S324-S325, September




(PDF 0-2 workdays service: $29.90)

Accession: 035349853

Download citation: RISBibTeXText



Related references

Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. Journal of Clinical Oncology 30(27): 3353-3360, 2012

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer Abstracted from: Andre T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:. Cancer Treatment Reviews 30(8): 711-713, 2004

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial. Strahlentherapie und Onkologie 192(7): 505-506, 2016

Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients between ages 7 and 75 years With Colon Cancer Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Tre. 2012

Final safety findings from a randomized phase III trial of capecitabine + oxaliplatin (XELOX) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with stage III colon cancer. Journal of Clinical Oncology 24(18_suppl): 3569-3569, 2016

Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer. Annals of Oncology 19(2): 340-347, 2007

Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study. Annals of Oncology 13(1): 103-107, 2002

Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients. Oncologist 19(5): 492-497, 2015

Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study. Investigational New Drugs 25(2): 173-180, 2006

Final results of a randomized phase III study evaluating the addition of oxaliplatin first line to 5-FU followed by irinotecan at progression in advanced colorectal cancer (LIFE study). Journal of Clinical Oncology 23(16_suppl): 3517-3517, 2016

Oxaliplatin and irinotecan chemotherapy in advanced gastric cancer. Final results of a multicenter phase II trial. Journal of Clinical Oncology 24(18_suppl): 4070-4070, 2016

Capecitabine in combination with oxaliplatin as first line therapy for patients with advanced or metastatic colorectal cancer Preliminary results of an international multicenter phase II study. European Journal of Cancer 37(Supplement 6): S272, October, 2001

Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Seminars in Oncology 28(1 Suppl 1): 14-19, 2001

Oxaliplatin/5FU/LV in the adjuvant treatment of stage II and stage III colon cancer: Efficacy results with a median follow-up of 4 years. Journal of Clinical Oncology 23(16_suppl): 3501-3501, 2016

Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study. Onkologie 28(6-7): 347-350, 2005